Cerebral aspergillosis under ibrutinib therapy: clinical features and management challenges. Serris A, Danion F, Benzakoun J, Tattevin P, et al. J Antimicrob Chemother 2026;81:dkag266.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Serris A, Danion F, Benzakoun J, Tattevin P, et al. Cerebral aspergillosis under ibrutinib therapy: clinical features and management challenges. J Antimicrob Chemother 2026;81:dkag266.
PMID: 42549568